THERADOME RECRUITS MEN WITH THINNING HAIR TO TEST OVER-THE-COUNTER LASER HELMET FOR HAIR RESTORATION
Pleasanton, California. – August 25, 2015 – Theradome Inc., home to the first FDA-cleared and over-the-counter wearable hair restoration device for women, has begun one of the most comprehensive studies in Laser Phototherapy to date. The study will gauge the success of the Theradome LH80 PRO Laser Helmet on men with thinning hair or who are showing signs of balding. Northwest Dermatology in Portland, OR, MedaPhase LLC in Atlanta, GA, and the Tennessee Clinical Research Center in Nashville, TN, are recruiting men ages 18 to 50 that have been diagnosed with androgenetic alopecia to participate in a 26-week clinical trial study. Dr. Ken Washenik MD, Ph.D., a leading physician and clinical researcher in hair loss, is providing medical oversight for Theradome’s clinical study.
Developed by former NASA scientist Tamim Hamid, the Theradome Laser Helmet leverages Laser Phototherapy (also known as Low-Level Laser Light Therapy) to stimulate weak hair follicles by providing them with targeted laser energy, which improves cellular metabolism and protein synthesis required to grow and maintain a healthy head of hair.
“The positive response we’ve had to Theradome thus far has been absolutely overwhelming– not to mention very humbling,” says Hamid. “We are now diligently working to bring men those same benefits as seen in women using the device around the globe.”
Previously only available to dermatologists and specialized hair loss clinics, laser-based hair restoration therapy has since come a long way. Theradome’s LH80 PRO can be worn twice a week for 20 minutes in the comfort of an individual’s home, and most subjects have reported seeing results in only 18 weeks.
The double-blind, sham controlled, randomized and multi-centered study will test Theradome LH80 PRO’s ability to promote hair growth in men when compared to what is known as a “Sham Device”, a fake Laser Phototherapy unit worn by a control group unaware of the helmet’s authenticity.
For more information and a complete list of eligibility requirements, please visit https://clinicaltrials.gov/ct2/show/NCT02528552?term=theradome&rank=1 .